DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Sorting nexin 27-dependent regulation of Lck and CD4 tunes the initial stages of T-cell activation
Sorting nexin 27 is a unique member of the sorting nexin family of proteins that mediates the endosome-to-plasma membrane trafficking of cargos bearing a PSD95/Dlg1/ZO-1 (PDZ)-binding motif. In brain, sorting nexin 27 regulates synaptic plasticity, and its dysregulation contributes to cognitive impairment and neuronal degeneration. In T lymphocytes, sorting nexin 27 partners with diacylglycerol kinase ζ to facilitate polarized traffic and signaling at the immune synapse. By silencing sorting nexin 27 expression in a human T-cell line, we demonstrate that sorting nexin 27 is a key regulator of the early T-cell tyrosine-based signaling cascade. Sorting nexin 27 transcriptionally controls CD4 abundance in resting conditions and that of its associated molecule, Lck. This guarantees the adequate recruitment of Lck at the immune synapse, which is indispensable for subsequent activation of tyrosine phosphorylation-regulated events. In contrast, reduced sorting nexin 27 expression enhances NF-κB-dependent induction of CXCR4 and triggers production of lytic enzymes and proinflammatory cytokines. These results provide mechanistic explanation to previously described sorting nexin 27 function in the control of immune synapse organization and indicate that impaired sorting nexin 27 expression contributes to CD4 T-cell dysfunction., C.R.-R. held a predoctoral fellow of the Álvaro Entrecanales and Jérôme Lejeune Foundations. N.G.-M. received funding from the
European Union Horizon 2020-Marie Sklodowska-Curie Actions (grant agreement 713673) and “La Caixa” Foundation (ID
100010434), with the fellowship code being LCF/BQ/DI17/11620027, as well as an European Molecular Biology Organization (EMBO) scientific exchange grant. A.O.-E. receives funds from predoctoral contract PRE2023_CNB-035 funded by the Ministerio de Ciencia,
Innovación y Universidades (MICU/AEI/10.13039/501100011033and FSE +). Research in Merida’s lab is funded by grants
PID2019-108357RB-100 and PID2022-136871OB-100 funded by the Ministerio de Ciencia, Innovación y Universidades (MICU/AEI/
10.13039/501100011033) and Fondo Europeo de Desarrollo Regional FEDER, UE, and Next Generation EU (Regulation EU
2020/2094) through Consejo Superior de Investigaciones Científicas Global Health Platform (PTI Salud Global) to I.M., Peer reviewed
Project:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-108357RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136871OB-I00
DOI: http://hdl.handle.net/10261/374438, https://api.elsevier.com/content/abstract/scopus_id/85200886283
HANDLE: http://hdl.handle.net/10261/374438, https://api.elsevier.com/content/abstract/scopus_id/85200886283